Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Complement Factor H-related 2/CFHR2/CFHL2 Antibody (005), Allophycocyanin, Novus Biologicals™
SDP

Catalog No. NB334081 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB334081 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB334081 Supplier Novus Biologicals Supplier No. NBP290262APC
Add to Cart
Add to Cart

Rabbit Monoclonal Antibody

Complement Factor H-related 2/CFHR2/CFHL2 Monoclonal antibody specifically detects Complement Factor H-related 2/CFHR2/CFHL2 in Human samples. It is validated for ELISA

Specifications

Antigen Complement Factor H-related 2/CFHR2/CFHL2
Applications ELISA
Classification Monoclonal
Clone 005
Conjugate APC
Dilution ELISA
Formulation PBS
Gene Alias CFHL2FHR-2, complement factor H-related 2, factor H-related gene 2, FHR2DDESK59, H factor (complement)-like 3, H factor-like 3, H factor-like protein 2, HFL3complement factor H-related protein 2
Host Species Rabbit
Immunogen Rabbit immunized with purified, recombinant Human Complement Factor H-related 2/CFHR2/CFHL2 (Uniprot#: P36980-1, Met1-Lys270)
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3080
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.